Pharma News

An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria.

Doubling its Series B raise last year, clinical-stage pharmaceutical company Imago Biosciences raked in $80 million this week to take their lead candidate through a Phase III trial.

LONDON — The coronavirus vaccine being developed by the University of Oxford and AstraZeneca could still be made available at a similar time to the other leading candidates, according to the head of...

Amazon has been quietly building out its pharmacy offering for several years after ramping up internal discussions in 2017 and acquiring PillPack in 2018.

Scientists are reporting promising results from a phase 2 clinical trial of a cholesterol-reducing drug called evinacumab.

As the COVID-19 pandemic fuels a global interest in healthcare, many deep-pocketed investors have diverted their money to the sector.

A drug used to treat rheumatoid arthritis may reduce the risk of dying for elderly patients with Covid-19, and provide a new weapon in the arsenal against the novel coronavirus, according to a study.

AstraZeneca’s P2Y12 receptor antagonist Brilinta reduced the rate of stroke and death in a prespecified, high-risk subgroup, according to new analysis of the phase III THALES trial.

GlaxoSmithKline subsidiary ViiV Healthcare has announced that its long-acting injectable cabotegravir has scored a breakthrough therapy designation (BTD) from the US Food and Drug Administrati...

States and hospital systems across the US have started panic-buying ultra low temperature freezers capable of storing Pfizer's coronavirus vaccine.

SEOUL (Reuters) - Samsung BioLogics Co Ltd on Tuesday said it is mass-producing a COVID-19 antibody treatment developed by Eli Lilly and Co, as the United States began distributing the drug la...

Cardiff University researchers found that mouthwash emanating from the mouth contained 0.